Literature DB >> 28545855

[A complex case of diabetes due to LMNA mutation].

C Ambonville1, M-A Bouldouyre2, P Laforêt3, P Richard4, O Benveniste5, C Vigouroux6.   

Abstract

INTRODUCTION: Laminopathies (diseases related to A/C mutations of lamines) are rare genetic diseases with an extensive phenotypic spectrum, including lipodystrophic syndromes-characterized by a selective loss of adipose tissue-of which the partial Dunnigan family type is the most frequent. CASE REPORT: We report on a 55-year-old woman with diabetes and long-term disabling myalgia. Her cushingoid morphotype, associated with cutaneous lipo-atrophy and muscle hypertrophy in addition to a genetic heritage, led us to the diagnosis of complex partial familial lipodystrophy heterozygous LMNA_c.82C>T, p.Arg28Trp mutation.
CONCLUSION: Familial partial lipodystrophic syndromes may have varied phenotypes, mainly cardio-metabolic, which could mimic a particularly severe type 2 diabetes. The diagnostic work-up of this disease has to include a careful investigation of gait troubles and paroxysmal conduction that could lead to sudden death, as well as a genetic examination. In some cases, recombinant leptin can be proposed.
Copyright © 2017 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Cardiopathie; Cardiopathy; Diabetes mellitus; Diabète; Dominant autosomal transmission; Familial partial lipodystrophy; LMNA; Laminopathies; Lipodystrophies familiales partielles; Myalgies; Myopathy; Transmission autosomique dominante

Mesh:

Substances:

Year:  2017        PMID: 28545855     DOI: 10.1016/j.revmed.2017.04.006

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  1 in total

1.  Unraveling LMNA Mutations in Metabolic Syndrome: Cellular Phenotype and Clinical Pitfalls.

Authors:  Camille Desgrouas; Alice-Anaïs Varlet; Anne Dutour; Damien Galant; Françoise Merono; Nathalie Bonello-Palot; Patrice Bourgeois; Adèle Lasbleiz; Cathy Petitjean; Patricia Ancel; Nicolas Levy; Catherine Badens; Bénédicte Gaborit
Journal:  Cells       Date:  2020-01-28       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.